ASH 2024 | Lymphoma and Multiple Myeloma Highlights
We are pleased to invite you to attend this interactive, scientific-exchange meeting, where experts will present multiple myeloma and lymphoma data highlights from the ASH 2024 congress.
Following each expert presentation there will be an open discussion; you are strongly encouraged to take this opportunity to put your thoughts and questions to the speakers and engage in this interactive discussion and debate.
This non-promotional, scientific exchange meeting is organised and funded by the medical department of Takeda UK Ltd and is intended for healthcare professionals from the UK and Ireland with a clinical speciality in haemato-oncology only.
Agenda Details
The meeting can be attended in person or via live webcast. For those attending in person, registration and a hot buffet will be available from 17:10.
Welcome and introduction
The Freeman Hospital, Newcastle upon Tyne
Lymphoma diagnostics
St James’s University Hospital, Leeds
Interactive discussion and debate
High-grade lymphoma
The Freeman Hospital, Newcastle upon Tyne
Interactive discussion and debate
Chornic lymphocytic leukemia and low-grade lymphoma
The Freeman Hospital, Newcastle upon Tyne
Interactive discussion and debate
Coffee break
Hodgkin lymphoma and T-cell lymphoma
Churchill Hospital, Oxford
Interactive discussion and debate
Multiple myeloma
Churchill Hospital, Oxford
Interactive discussion and debate
Panel discussion and debate
Close
The Freeman Hospital, Newcastle upon Tyne
Dr Wendy Osborne (Chair)
Consultant Haematologist
The Freeman Hospital, Newcastle upon Tyne
Dr Cathy Burton
Consultant Haematologist
St James’s University Hospital, Leeds
Dr Helen Marr
Consultant Haematologist
The Freeman Hospital, Newcastle upon Tyne
Dr Tobias Menne
Consultant Haematologist
The Freeman Hospital, Newcastle upon Tyne
Professor Graham Collins
Consultant Haematologist
Churchill Hospital, Oxford
Dr Karthik Ramasamy
Consultant Haematologist
Churchill Hospital, Oxford